133 related articles for article (PubMed ID: 10036228)
1. The cytoplasmic carboxy-terminal amino acid determines the subcellular localization of proTGF-(alpha) and membrane type matrix metalloprotease (MT1-MMP).
Ureña JM; Merlos-Suárez A; Baselga J; Arribas J
J Cell Sci; 1999 Mar; 112 ( Pt 6)():773-84. PubMed ID: 10036228
[TBL] [Abstract][Full Text] [Related]
2. The cytoplasmic carboxy-terminal amino acid specifies cleavage of membrane TGF alpha into soluble growth factor.
Bosenberg MW; Pandiella A; Massagué J
Cell; 1992 Dec; 71(7):1157-65. PubMed ID: 1473151
[TBL] [Abstract][Full Text] [Related]
3. Activated release of membrane-anchored TGF-alpha in the absence of cytosol.
Bosenberg MW; Pandiella A; Massagué J
J Cell Biol; 1993 Jul; 122(1):95-101. PubMed ID: 8314849
[TBL] [Abstract][Full Text] [Related]
4. A role for a PDZ protein in the early secretory pathway for the targeting of proTGF-alpha to the cell surface.
Fernández-Larrea J; Merlos-Suárez A; Ureña JM; Baselga J; Arribas J
Mol Cell; 1999 Apr; 3(4):423-33. PubMed ID: 10230395
[TBL] [Abstract][Full Text] [Related]
5. Diverse cell surface protein ectodomains are shed by a system sensitive to metalloprotease inhibitors.
Arribas J; Coodly L; Vollmer P; Kishimoto TK; Rose-John S; Massagué J
J Biol Chem; 1996 May; 271(19):11376-82. PubMed ID: 8626692
[TBL] [Abstract][Full Text] [Related]
6. Multiple metalloproteinases process protransforming growth factor-alpha (proTGF-alpha).
Hinkle CL; Mohan MJ; Lin P; Yeung N; Rasmussen F; Milla ME; Moss ML
Biochemistry; 2003 Feb; 42(7):2127-36. PubMed ID: 12590602
[TBL] [Abstract][Full Text] [Related]
7. Role of the juxtamembrane domains of the transforming growth factor-alpha precursor and the beta-amyloid precursor protein in regulated ectodomain shedding.
Arribas J; López-Casillas F; Massagué J
J Biol Chem; 1997 Jul; 272(27):17160-5. PubMed ID: 9202036
[TBL] [Abstract][Full Text] [Related]
8. The shedding of betaglycan is regulated by pervanadate and mediated by membrane type matrix metalloprotease-1.
Velasco-Loyden G; Arribas J; López-Casillas F
J Biol Chem; 2004 Feb; 279(9):7721-33. PubMed ID: 14672946
[TBL] [Abstract][Full Text] [Related]
9. Metalloprotease-dependent protransforming growth factor-alpha ectodomain shedding in the absence of tumor necrosis factor-alpha-converting enzyme.
Merlos-Suárez A; Ruiz-Paz S; Baselga J; Arribas J
J Biol Chem; 2001 Dec; 276(51):48510-7. PubMed ID: 11600492
[TBL] [Abstract][Full Text] [Related]
10. Phorbol ester-induced activation of a membrane-bound candidate pro-transforming growth factor-alpha processing enzyme.
Harano T; Mizuno K
J Biol Chem; 1994 Aug; 269(32):20305-11. PubMed ID: 8051125
[TBL] [Abstract][Full Text] [Related]
11. Pro-tumor necrosis factor-alpha processing activity is tightly controlled by a component that does not affect notch processing.
Merlos-Suárez A; Fernández-Larrea J; Reddy P; Baselga J; Arribas J
J Biol Chem; 1998 Sep; 273(38):24955-62. PubMed ID: 9733803
[TBL] [Abstract][Full Text] [Related]
12. Regulation of membrane-type-1 matrix metalloproteinase activity by its cytoplasmic domain.
Lehti K; Valtanen H; Wickström SA; Lohi J; Keski-Oja J
J Biol Chem; 2000 May; 275(20):15006-13. PubMed ID: 10748199
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor alpha: expression, regulation and biological action of its integral membrane precursor.
Luetteke NC; Lee DC
Semin Cancer Biol; 1990 Aug; 1(4):265-75. PubMed ID: 2103501
[TBL] [Abstract][Full Text] [Related]
14. Inactivating mutations block the tumor necrosis factor-alpha-converting enzyme in the early secretory pathway.
Villanueva de la Torre T; Bech-Serra JJ; Ruiz-Paz S; Baselga J; Arribas J
Biochem Biophys Res Commun; 2004 Feb; 314(4):1028-35. PubMed ID: 14751236
[TBL] [Abstract][Full Text] [Related]
15. Membrane-type 1 matrix metalloproteinase cytoplasmic tail-binding protein-1 is a new member of the Cupin superfamily. A possible multifunctional protein acting as an invasion suppressor down-regulated in tumors.
Uekita T; Gotoh I; Kinoshita T; Itoh Y; Sato H; Shiomi T; Okada Y; Seiki M
J Biol Chem; 2004 Mar; 279(13):12734-43. PubMed ID: 14718544
[TBL] [Abstract][Full Text] [Related]
16. Loss of ectodomain shedding due to mutations in the metalloprotease and cysteine-rich/disintegrin domains of the tumor necrosis factor-alpha converting enzyme (TACE).
Li X; Fan H
J Biol Chem; 2004 Jun; 279(26):27365-75. PubMed ID: 15075334
[TBL] [Abstract][Full Text] [Related]
17. TACE is required for the activation of the EGFR by TGF-alpha in tumors.
Borrell-Pagès M; Rojo F; Albanell J; Baselga J; Arribas J
EMBO J; 2003 Mar; 22(5):1114-24. PubMed ID: 12606576
[TBL] [Abstract][Full Text] [Related]
18. Human keratinocytes and tumor-derived cell lines express alternatively spliced forms of transforming growth factor-alpha mRNA, encoding precursors lacking carboxyl-terminal valine residues.
Xu X; Liao J; Creek KE; Pirisi L
Oncogene; 1999 Sep; 18(40):5554-62. PubMed ID: 10523832
[TBL] [Abstract][Full Text] [Related]
19. Integral membrane glycoprotein properties of the prohormone pro-transforming growth factor-alpha.
Teixidó J; Gilmore R; Lee DC; Massagué J
Nature; 1987 Apr 30-May 6; 326(6116):883-5. PubMed ID: 3574460
[TBL] [Abstract][Full Text] [Related]
20. Unique carboxyl-terminal sequences of wild type and alternatively spliced variant forms of transforming growth factor-alpha precursors mediate specific interactions with ErbB4 and ErbB2.
Xu X; Kelleher KF; Liao J; Creek KE; Pirisi L
Oncogene; 2000 Jun; 19(28):3172-81. PubMed ID: 10918572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
